Kestra Medical Technologies (KMTS) Interest Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Interest Expenses data on file, last reported at $1.9 million in Q1 2026.

• Interest Expenses for Q1 2026 came in at $1.9 million, up 5.89% year-over-year; the trailing twelve-month figure through Jan 2026 was $7.5 million (down 5.66% YoY), and the FY2025 annual result was $7.7 million, up 24.14% from the prior year.
• Interest Expenses slipped to $1.9 million in Q1 2026 per KMTS's latest filing, from $1.9 million in the prior quarter.
• Over five years, Interest Expenses peaked at $2.3 million in Q4 2024 and troughed at $1.7 million in Q1 2024.
• A 3-year average of $1.9 million and a median of $1.9 million in 2026 frame the typical range for Interest Expenses.
• On a YoY basis, Interest Expenses climbed as much as 8.0% in 2025 and fell as far as 17.95% in 2025.
• A 3-year view of Interest Expenses shows it stood at $2.3 million in 2024, then decreased by 17.95% to $1.9 million in 2025, then declined by 0.68% to $1.9 million in 2026.
• Business Quant data shows KMTS's Interest Expenses at $1.9 million in Q1 2026, $1.9 million in Q4 2025, and $1.9 million in Q3 2025.